Studies in animal models indicates that BP-157 can enhanced blood vessel formation (angiogenesis), promote wound healing, stimulate collagen synthesis, modulate the inflammatory response, and protect against oxidative stress
The ability of oral semaglutide to improve glycaemic control and reduce body weight, as well as its effect on other clinical outcomes, are currently being investigated in phase III clinical trials
What is the difference between GLP-1 signaling and GLP-1 levels
The legal machinery the Orange Book listings, the Hatch-Waxman stays, the BPCIA litigation remains in place
Others may feel queasy or tired during the adjustment period
Regular monitoring of blood sugar, kidney function, and metabolic markers ensures safety during extended therapy